Systematic Review in Patients with Benign Prostatic Hyperplasia for The Role of Prostatic Arterial Embolization

Abstract

This study aimed at reviewing the role of Prostatic Arterial Embolization (PAE) as a new treatment producer for patients with Benign Prostatic Hyperplasia (BPH). The study reviewed the recent researches of  Prostatic Arterial Embolization (PAE) as a new treatment technique and concluded that the initial reported results of PAE seem promising, mainly during the first 12 months after treatment. However, no comparison was made to medical therapy or surgical therapies. Overlapping patient data and reporting bias could not be excluded. None of the included studies performed a power analysis. Also, a relatively small number of patients are treated with a short follow-up period. Therefore, more studies are needed with more patients and longer periods of follow-up, compared with standard medical and surgical therapies, to assess whether PAE is an effective and safe alternative treatment for BPH.